International Journal of Molecular Sciences | |
Expression of Aldo-Keto Reductase Family 1 Member B10 in the Early Stages of Human Hepatocarcinogenesis | |
Hironori Tsuzura2  Takuya Genda2  Shunsuke Sato2  Ayato Murata2  Yoshio Kanemitsu2  Yutaka Narita2  Sachiko Ishikawa2  Tetsu Kikuchi2  Masashi Mori2  Katsuharu Hirano2  Katsuyori Iijima2  Ryo Wada1  | |
[1] Department of Pathology, Juntendo University Shizuoka Hospital, 1129 Nagaoka, Izunokuni-shi, Shizuoka 410-2295, Japan; E-Mail:;Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, 1129 Nagaoka, Izunokuni-shi, Shizuoka 410-2295, Japan; E-Mails: | |
关键词: AKR1B10; HSP70; glypican-3; hepatocellular carcinoma; chronic hepatitis; cirrhosis; | |
DOI : 10.3390/ijms15046556 | |
来源: mdpi | |
【 摘 要 】
Aldo-keto reductase family 1, member B10 (AKR1B10), a cancer-related oxidoreductase, is expressed in well-differentiated hepatocellular carcinomas (HCCs). However, AKR1B10 levels are minimal in normal liver tissues (NLs), similar to the 70-kilodalton heat shock protein (HSP70) and glypican-3. Moreover, the role of AKR1B10 in chronic hepatitis or cirrhosis, which are considered preneoplastic conditions for HCC, has not been fully elucidated. The aim of this study was to evaluate the expression of AKR1B10, HSP70, and glypican-3 in 61 HCC tissue samples compared to corresponding non-tumorous liver tissues (NTs), comprising 42 chronic hepatitis and 19 cirrhosis cases to clarify the significance of molecular changes at the preneoplastic stages of HCC. Immunohistochemical analysis demonstrated that the median expression levels of AKR1B10 were higher in HCCs than in NTs (
【 授权许可】
CC BY
© 2014 by the authors; licensee MDPI, Basel, Switzerland
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190026683ZK.pdf | 837KB | download |